Form 4: Metagenomi Executive Simren Delaney Reports Stock and Option Awards

Simren Delaney, a Vice President at Metagenomi, reported the acquisition of restricted stock units and stock options.

Summary

• On April 1, 2024, Simren Delaney, Vice President of Intellectual Property and Legal Operations at Metagenomi, acquired 6,931 shares of common stock in the form of restricted stock units (RSUs) and options to purchase 29,145 shares of common stock.
• The RSUs vest 25% on June 5, 2025, and the remainder in 12 equal quarterly installments.
• The options vest 25% on April 1, 2025, and the remainder in 36 equal monthly installments, contingent upon continued service with the company.
• Following these transactions, Delaney directly owns 93,892 shares of common stock and options to purchase 29,145 shares.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock and option awards, with no inherent positive or negative implications for the company's performance.

Future Outlook

The vesting schedules for both the RSUs and stock options are contingent upon the Reporting Person's continued service with the Issuer.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and equity ownership of company executives.

Stakeholder Impact

• The vesting of RSUs and stock options aligns the executive's interests with those of the shareholders, incentivizing them to contribute to the company's long-term success.

Key Dates